Single oral dose cure of lethal P. yoelii with a new iron chelator in human clinical trials for iron overload

Malaria Journal

Poster Presentations

Hugh Rienhoff¹  Abhai Tripathi² 

[1] FerroKin BioSciences, Inc., San Carlos, CA, USA;The Malaria Research Institute, W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;

关键词: Malaria;    Iron Overload;    Iron Chelator;    Deferoxamine;    Human Clinical Trial;   

DOI  :  10.1186/1475-2875-9-S2-P54

来源: Springer

【 授权许可】

Unknown   
© Tripathi et al; licensee BioMed Central Ltd. 2010. This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.